ExpreS2ion Biotech Holding AB (EXPRS2)
Market Closed
10 Aug, 15:25
XSTO XSTO Primary XSTO kr
1. 46
+0.03
+2.4561%
kr
- Market Cap
- P/E Ratio
- Div Yield
129,070 Volume
- Eps
kr 1.43
Previous Close Want to track EXPRS2 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
ExpreS2ion Biotech Holding AB (EXPRS2) Statistics
Valuation metrics
Market Cap -
Enterprise value -16.96M
Trailing P/E (ttm) -0.14
Forward P/E -
PEG ratio -0.03
Price/Sales (ttm) 1.08
Price/Book (mrq) 0.53
Enterprise Value/Revenue -5.04
Enterprise Value/EBITDA 0.33
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 87.06K
Average volume (90 days) 91.23K
Price summary
52-Week low 1.65
52-Week high 28.55
Beta -
50-Day moving average 1.44
200-Day moving average 5.36
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:40
Last split Date 30 Oct 2024
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -10.77%
Operating margin -16.18%
Operational effectiveness
Return on assets -0.72%
Return on equity -1.05%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.34
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -3.67
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.21
Total debt (mrq) -
Total Debt/Equity (mrq) 0.05
Current ratio (mrq) 1.87%
Book value per share (mrq) 2.67
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
